CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
Jong Gwon Choi, Jae Hong Seo, Sang Cheul Oh, Chul Won Choi, Jun Suk Kim
Cancer Research and Treatment. 2012;44(2):127-132.   Published online 2012 June 30    DOI: https://doi.org/10.4143/crt.2012.44.2.127

Excel Download

A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
Cancer Research and Treatment. 2012;44(2):127-132   Crossref logo
Link1 Link2

Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer
Annals of Oncology. 2008;19(2):340-347   Crossref logo
Link1 Link2 Link3

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
Breast Diseases: A Year Book Quarterly. 2011;22(4):413-415   Crossref logo
Link1 Link2

Gemcitabine plus capecitabine is effective in advanced pancreatic cancer
Nature Clinical Practice Oncology. 2007;4(9):504-504   Crossref logo
Link1 Link2 Link3

735 POSTER Randomized comparison of capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (GemOx) in advanced pancreatic cancer
European Journal of Cancer Supplements. 2005;3(2):209   Crossref logo
Link1 Link2

779 PUBLICATION Phase I trial of capecitabine and gemcitabine with concurrent radical radiotherapy in locally advanced pancreatic cancer: interim results
European Journal of Cancer Supplements. 2005;3(2):222   Crossref logo
Link1 Link2

6512 A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel
European Journal of Cancer Supplements. 2009;7(2):365   Crossref logo
Link1 Link2

PS11 Best of ECCO 13 Phase III randomised comparison of gemcitabine (GEM) versus gemcitabine plus capecitabine (GEM-CAP) in patients with advanced pancreatic cancer
European Journal of Cancer Supplements. 2005;3(4):12   Crossref logo
Link1 Link2

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
British Journal of Cancer. 2011;104(7):1071-1078   Crossref logo
Link1 Link2 Link3

Gemcitabine plus capecitabine in elderly patients with advanced pancreatic cancer
Annals of Oncology. 2017;28:iii76   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.